Sofinnova: Industrial biotech promotionEuropean venture capital firm Sofinnova Partners announced the promotion of Michael Krel to Partner of the Industrial Biotechnology team. Krel previously served as Principal on the team, where he focused … more ➔
Ipsen: New VP and CMO incoming Ipsen has named steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance, effective March 2020. more ➔
Wellington Partners: Sideways moveKarl Naegler, who has been a partner at the investment company Gimv since 2011, has joined the competition. He is now Managing Partner at leading European venture capital firm Wellington Partners. more ➔
Zelluna: Scientist turns CEONorwegian biopharma company Zelluna Immunotherapy appointed erstwhile CSO Namir Hassan as Chief Executive Officer. more ➔
Creoptix: New woman at the helmCreoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, has named Line Stigen Raquet as Chief Executive Officer. more ➔
Inceptua: Risen through the ranksLuxembourg-based Inceptua has named Stefan Fraenkel as its new CEO. Fraenkel has been in charge of creating the Inceptuas business unit Inceptua Pharma since 2017. more ➔
ECBF: Investment proThe European Circular Bioeconomy Fund, which aims to provide financing for innovative circular bioeconomy companies and projects in the EU and in countries associated with the Horizon 2020 programme, … more ➔
Mogrify: Decorated chair At the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech … more ➔
Roche Diagnostics: Up the ladderClaus Haberda will be the new Managing Director at Roche Diagnostics GmbH, succeeding Ursula Redeker, who will return to Basel. more ➔
Arctoris: John Mattick on boardJohn Mattick has been appointed to the Board of Directors of Oxford-based research company Arctoris Ltd. more ➔
